Prevention of invasive pneumococcal disease in HIV-infected children: expanding the toolbox.
Abzug
Mark J
MJ
Pelton
Stephen I
SI
D019380:Anti-HIV Agents / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D002648:Child; D002675:Child, Preschool; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology; D000069443:Heptavalent Pneumococcal Conjugate Vaccine; D006801:Humans; D007223:Infant; D011008:Pneumococcal Infections / Q000150:complications* / Q000453:epidemiology / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000008:administration & dosage / Q000592:standards; D013019:South Africa / Q000453:epidemiology; D014481:United States / Q000453:epidemiology
D019380:Anti-HIV Agents; D000069443:Heptavalent Pneumococcal Conjugate Vaccine; D022242:Pneumococcal Vaccines